Friday 6 November 2026 Export ATRC’s income statement to Excel — free account

AtriCure, Inc.

ATRC Healthcare Medical Instruments & Supplies

AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.

Revenue: +15.0%
EPS: +1,583.9%
Free cash flow: −0.73%
Total debt: −17.3%

Quarter to September 2026, against a year earlier

59.36 1.92 −3.13%

Follow ATRC

Alert me

Market cap: $3.1B
P/E: 199×
Fwd P/E: 573×
Dividend yield: —
F-score: 7/9
Altman Z: 7.31
Beneish M: −2.91
Dividend safety: n/a

Overview

AtriCure, Inc. (ATRC) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, AtriCure, Inc. (ATRC) trades at a price to free cash flow of 129×. Over the past ten years it has ranged from 0.0× (September 2025) to 676× (December 2025); the current reading is higher than 98% of that period. That is above the Medical Instruments & Supplies industry median of 23.5× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ATRC/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="AtriCure, Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ATRC/metrics/price-to-free-cash-flow">AtriCure, Inc. (ATRC) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	103×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	Price to free cash flow	Change
Sep 2026	120×	103.35%
Jun 2026	58.9×	1.01%
Mar 2026	58.3×	(43.55%)
Dec 2025	103×	(81.64%)
43 more quarters	Free account

Against its own ten years

Low 0.0× High 676×

Ten-year median 0.0×

Current reading's percentile 98

Company	Price to free cash flow
STVN Stevanato Group S.p.A. compare	n/m
PLSE Pulse Biosciences, Inc compare	n/m
MMED MiniMed Group, Inc. compare	n/m
NVST Envista Holdings Corporation compare	16.4×
XRAY DENTSPLY SIRONA Inc. compare	21.1×
ICUI ICU Medical, Inc. compare	21.2×
MMSI Merit Medical Systems, Inc. compare	23.6×
ATRC AtriCure, Inc.	129×
WRBY Warby Parker Inc. compare	153×
Medical Instruments & Supplies industry median	23.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

AtriCure, Inc. (ATRC) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on ATRC

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on ATRC

Stockrow Weekly